Wearable makers have spent a decade selling the promise that better data means better health decisions. Oura’s latest move is an attempt to close the gap between having that data and actually doing something useful with it. Since June 16, 2026, the company has been rolling out an integration with Counsel Health, an AI-native primary care startup, that lets Oura Ring members chat with a medical AI at any time and escalate to a board-certified physician without leaving the Oura app. On September 17, 2026, Counsel Health announced it is extending the partnership further, joining the Centers for Medicare and Medicaid Services’ ACCESS Model to bring AI-native chronic care for hypertension, obesity, hyperlipidemia and prediabetes to Medicare beneficiaries starting in early 2027.
How the Counsel integration actually works
According to Oura’s own announcement, members who opt in can share sleep, cardiovascular and reproductive health trends collected by their ring directly with Counsel’s medical AI during a conversation. The AI can offer proactive suggestions when it notices a meaningful change in someone’s data, and if the situation calls for it, the conversation escalates to an asynchronous consultation with a Counsel physician. Dr. Ricky Bloomfield, Oura’s Chief Medical Officer, framed the pitch around a gap the company has long acknowledged in its own product: “Understanding is only part of the story” — when a member faces a new symptom, he said, they need a trustworthy path forward. Access started in Oura Labs, the company’s early-access testing tier, and reached 43 states at launch, excluding Arkansas, Washington D.C., Kansas, Mississippi, Rhode Island, Washington state, West Virginia and Wisconsin, largely due to state-by-state telehealth licensing rules.
From wellness ring to front door for medical care
The arrangement reflects a broader repositioning underway among wearable makers, who have spent years building trust around biometric tracking and are now trying to convert that trust into paid healthcare relationships. Under the current setup, chatting with Counsel’s medical AI is included in an Oura Membership subscription, but actual physician visits and any resulting treatment carry additional costs, meaning the ring itself becomes a funnel toward a separate telehealth business rather than a replacement for one. Counsel and Oura have both stressed that Counsel is HIPAA-compliant and SOC 2 certified, and that neither company sells member data collected through the integration, an assurance aimed at defusing the privacy concerns that have dogged consumer health-data partnerships in the past.
Medicare is the bigger prize
The September 17 announcement pushes the partnership into far higher-stakes territory. CMS’s ACCESS Model is a federal pilot designed to test whether new care-delivery approaches, in this case AI-supported chronic disease management paired with continuous wearable data, can improve outcomes and lower costs for Medicare beneficiaries managing conditions like hypertension and prediabetes. If Counsel and Oura can show that ring-derived data plus an AI-native care loop keeps beneficiaries out of emergency rooms and stabilizes chronic conditions, it would be a significant validation for an industry that has struggled to prove clinical, reimbursable value beyond wellness scoring. Counsel’s plan calls for the Medicare-focused chronic care offering to launch in early 2027, giving both companies more than a year to work out the regulatory and clinical protocols required for a federal program.
Why some clinicians remain cautious
Physicians who work in digital health have welcomed the idea of wearable data feeding directly into a care pathway, but several have raised concerns about over-reliance on AI-mediated triage for older, often more medically complex Medicare patients. Critics note that consumer wearables, even ones with FDA-cleared features like ECG apps, are not diagnostic-grade for many of the conditions Counsel’s chronic-care program targets, and that an AI chat interface could either under-triage a serious symptom or over-triage minor fluctuations into unnecessary physician escalations. There is also the practical question of adoption: Medicare beneficiaries are a demographic with lower wearable ownership than younger adults, even as AARP reported that 36% of U.S. adults over 50 now own some kind of wearable device, according to industry research cited widely this year.
What comes next
For now, the Oura-Counsel integration remains a beta feature limited to members who opt into Oura Labs, and the Medicare expansion is still more than a year from actually reaching beneficiaries. But the direction of travel is clear: wearable companies are no longer content to be data collectors sitting outside the healthcare system, and the ACCESS Model gives Oura and Counsel a real shot at federal reimbursement if the pilot demonstrates cost savings. Whether regulators, clinicians and older patients trust an AI-first version of that pathway enough to use it will determine if this becomes a template other wearable makers race to copy, or a cautionary case study in moving too fast from ring to prescription.
Photo: Peggy_Marco / PIXABAY via Pixabay
